comprehensive -WSS

comprehensive

author：entertainment 2025-09-03 09:37:37 - browse：69

UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to more seniors getting care, a spike in demand for behavioral health services, and an influx of members with higher health needs.

“Those three elements, the senior trend piece, the behavioral piece, and then the effects of the strong growth is really what explains what’s going on,” UnitedHealth Group CEO Andrew Witty said on the company’s earnings call on Friday. “We’ll continue to lean into that growth very assertively.”

Minnetonka, Minn.-based UnitedHealth Group’s Optum segment, which includes its provider arm, its pharmacy benefit manager, and its data and technology arm, reported an operating margin of 6.6% in the quarter ended June 30, compared with 7.3% in the prior-year period. Leaders said the decline was within its provider arm, Optum Health.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Anavex keeps shifting the goalposts in its clinical trials

WSS

How to use technology to prevent future drug shortages

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

What to know about Virgin Galactic's 1st mission taking paying customers to space

In Memoriam: Notable people who died in 2023

Dobbs anniversary: the lost opportunity of abortion as health care

Bright Health sells Medicare Advantage business to Molina

Wikipedia

comprehensive

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

South Korea throws huge K

Drug repurposing or repositioning? The language matters

State Dept. review finds Biden bears some blame for Afghanistan failures

Activists slam private health insurers over coverage restrictions

BioMarin wins approval for gene therapy to treat hemophilia A

Guidelines to prevent youth baseball injuries need more muscle

Why failed clinical trials don’t always spell doom for a new drug

Wildfire smoke exposes gaps in outdoor worker protections

Peter Hotez and the public health issue of online harassment

leisure time

Why failed clinical trials don’t always spell doom for a new drug

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

American woman, child freed after being kidnapped in Haiti last month

The best solution to the drug shortages problem

DIEP, the 'gold standard' of breast reconstruction, is under threat

Wegovy trial has doctors encouraged over new possibilities

hotspot

hotspot

hotspot

focus